# Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada

> **NCT00528060** · PHASE2 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 35 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Atazanavir
- **DRUG:** Ritonavir
- **DRUG:** Tenofovir/emtricitabine

## Key facts

- **NCT ID:** NCT00528060
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528060, "Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00528060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*